Ftse Mib
35.359,09
-0,14%
DAX
18.686,89
-0,21%
S&P 500
5.296,59
-0,01%
NASDAQ
16.709,13
0,06%
Bitcoin
65.998,80
1,16%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zai Lab Ltd (ZLAB) Zai Lab Ltd (ZLAB) Notizie

Zai Lab Ltd

ZLAB
19,975
0,045 (0,23%)
Ultimo aggiornamento: 15:40:31
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/5/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202413:30BWZai Lab Announces Participation in May and June Investor..
15/5/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202419:22EDGAR2Form 144 - Report of proposed sale of securities
14/5/202413:30BWZai Lab Announces Acceptance of Supplemental Biologics..
13/5/202402:20BWZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for..
08/5/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:09EDGAR2Form 8-K - Current report
08/5/202422:05BWZai Lab Announces First Quarter 2024 Financial Results and..
15/4/202413:30BWZai Lab to Announce First Quarter 2024 Financial Results and..
11/4/202413:30BWZai Lab Statement on Executive Management Team’s Agreement..
02/4/202413:30BWZai Lab Presentations at AACR 2024 Annual Meeting to..
01/4/202413:30BWZai Lab Partner Bristol Myers Squibb Announces Pivotal..
27/3/202414:29BWZai Lab Partner Novocure Announces METIS Phase 3 Clinical..
14/3/202400:05BWZai Lab to Present Data Highlighting ZL-1310, a Novel..
06/3/202422:01BWZai Lab to Present Final Overall Survival (OS) Data from..
06/3/202413:30BWZai Lab Announces Participation in March Investor Conference
04/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:12EDGAR2Form 8-K - Current report
27/2/202422:05BWZai Lab Announces Full-Year 2023 Financial Results and..
08/2/202422:37EDGAR2Form 8-K - Current report
25/1/202422:15BWZai Lab to Announce Full-Year 2023 Financial Results and..
10/1/202423:12BWZai Lab Announces The New England Journal of Medicine..
04/1/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202421:50EDGAR2Form 144 - Report of proposed sale of securities
03/1/202421:47EDGAR2Form 144 - Report of proposed sale of securities
03/1/202421:42EDGAR2Form 144 - Report of proposed sale of securities
22/12/202322:29EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
19/12/202313:30BWZai Lab Announces Participation in January Investor..
18/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202314:53GLOBEParatek Pharmaceuticals Announces Inclusion of Oral NUZYRA®..
13/12/202305:10BWZai Lab Announces the First Listing of VYVGART®..
17/11/202300:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:10EDGAR2Form 8-K - Current report
07/11/202322:05GLOBEZai Lab Announces Third Quarter 2023 Financial Results and..
03/11/202321:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202320:20EDGAR2Form 144 - Report of proposed sale of securities
26/10/202313:30GLOBEZai Lab Announces Participation in November Investor..
18/10/202313:30GLOBEZai Lab to Announce Third Quarter 2023 Financial Results and..
03/10/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202313:30GLOBEZai Lab Obtains Breakthrough Therapy Designation for..
08/9/202312:12EDGAR2Form 144 - Report of proposed sale of securities
30/8/202313:30GLOBEZai Lab Announces Breakthrough Therapy Designation Granted..
29/8/202313:38GLOBEZai Lab Announces Participation in September Investor..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 19,84 Min: 19,83 Max: 20,01
Chiusura: 19,93

La tua Cronologia

NASDAQ
ZLAB
Zai Lab
USOTC
TKCHF
Taoka Chemical (CE)
BIT
P12AG5
BNP PARIBAS ISSUANCE
EU
G746S
G746S
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network